José M Baeyens Selected Research

1- (2- (3,4- dichlorophenyl)ethyl)- 4- methylpiperazine

1/2020	Urinary bladder sigma-1 receptors: A new target for cystitis treatment.
1/2017	Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice.
2/2014	Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice.
3/2013	σ1 receptors are involved in the visceral pain induced by intracolonic administration of capsaicin in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José M Baeyens Research Topics

Disease

8	Hyperalgesia 01/2020 - 07/2009
8	Pain (Aches) 01/2020 - 03/2005
3	Nociceptive Pain 01/2020 - 07/2009
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 02/2014
2	Visceral Pain 01/2020 - 03/2013
2	Neuralgia (Stump Neuralgia) 01/2020 - 02/2014
2	Hypersensitivity (Allergy) 02/2014 - 07/2009
1	Neoplasms (Cancer) 01/2021
1	Painful Neuropathy 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Cystitis 01/2020
1	Edema (Dropsy) 01/2020
1	Hemorrhage 01/2020
1	Inflammation (Inflammations) 01/2017
1	Neuroblastoma 08/2007
1	Acute Pain 03/2005

Drug/Important Bio-Agent (IBA)

4	1- (2- (3,4- dichlorophenyl)ethyl)- 4- methylpiperazineIBA 01/2020 - 03/2013
4	Haloperidol (Haldol)FDA LinkGeneric 08/2015 - 11/2005
3	Sigma-1 ReceptorIBA 01/2020 - 02/2014
3	Capsaicin (Zostrix)FDA Link 04/2013 - 07/2009
3	Formaldehyde (Formol)FDA Link 04/2013 - 03/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 02/2014
2	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 03/2013
2	N,N- dipropyl- 2- (4- methoxy- 3- (2- phenylethoxy)phenyl)ethylamine monohydrochlorideIBA 01/2020 - 03/2013
2	Opioid Analgesics (Opioids)IBA 01/2017 - 01/2017
2	4- (4- (4- chlorophenyl)- 4- hydroxy- 1- piperidinyl)- 1- (4- fluorophenyl)- 1- butanolIBA 07/2009 - 11/2005
1	Pharmaceutical PreparationsIBA 01/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2021
1	Liposomes (Liposome)IBA 01/2021
1	2',3'-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphateIBA 01/2020
1	resiniferatoxinIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Irritants (Vesicants)IBA 01/2020
1	Peroxidase (Myeloperoxidase)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2020
1	Purinergic P2X ReceptorsIBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2017
1	CarrageenanIBA 01/2017
1	Methadone (Dolophine)FDA LinkGeneric 08/2015
1	Antineoplastic Agents (Antineoplastics)IBA 02/2014
1	CalciumIBA 02/2014
1	Molecular Chaperones (Chaperone, Molecular)IBA 02/2014
1	LigandsIBA 02/2014
1	Acetic Acid (Vinegar)FDA LinkGeneric 04/2013
1	Ketoprofen (Orudis)FDA LinkGeneric 03/2013
1	P-2 (P 2)IBA 08/2007
1	Pentazocine (Talwin)FDA LinkGeneric 08/2007

Therapy/Procedure

3	Analgesia 01/2020 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2021
1	Therapeutics 01/2021
1	Palliative Care (Palliative Therapy) 08/2015